-
1
-
-
0029004341
-
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
-
SHERRINGTON R, ROGAEV EI, LIANG Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995: 375: 754-60.
-
(1995)
Nature
, vol.375
, pp. 754-760
-
-
Sherrington, R.1
Rogaev, E.I.2
Liang, Y.3
-
2
-
-
0030028429
-
Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease
-
WRAGG M, HUTTON M, TALBOT C, and the Alzheimer's disease Collaborative Group. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 1996: 347: 509-12.
-
(1996)
Lancet
, vol.347
, pp. 509-512
-
-
Wragg, M.1
Hutton, M.2
Talbot, C.3
-
3
-
-
16144367382
-
Presenilin-1 polymorphism and Alzheimer's disease
-
KEHOE P, WILLIAMS J, LOVESTONE S. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996: 347: 1185.
-
(1996)
Lancet
, vol.347
, pp. 1185
-
-
Kehoe, P.1
Williams, J.2
Lovestone, S.3
-
4
-
-
0030603571
-
Presenilin-1 polymorphism and Alzheimer's disease
-
HIGUCHI S, MURAMATSU T, MATSUBARA S, ARAI H, SASAKI H. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996: 347: 1186.
-
(1996)
Lancet
, vol.347
, pp. 1186
-
-
Higuchi, S.1
Muramatsu, T.2
Matsubara, S.3
Arai, H.4
Sasaki, H.5
-
5
-
-
0030603571
-
Presenilin-1 polymorphism and Alzheimer's disease
-
SCOTT WK, GROWDON JH, ROSES AD, HAINES JL, PERICAK-VANCE MA. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996: 347: 1186-7.
-
(1996)
Lancet
, vol.347
, pp. 1186-1187
-
-
Scott, W.K.1
Growdon, J.H.2
Roses, A.D.3
Haines, J.L.4
Pericak-Vance, M.A.5
-
7
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
-
MCKHAAN G, DRACHMAN D, FOLSTEIN M, KATZMAN R, PRICE D, STADLAN EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984: 34: 934-44.
-
(1984)
Neurology
, vol.34
, pp. 934-944
-
-
Mckhaan, G.1
Drachman, D.2
Folstein, M.3
Katzman, R.4
Price, D.5
Stadlan, E.M.6
-
8
-
-
0026639249
-
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
-
CHUI HC, VICTOROFF JI, MARGOLIN D, JAGUST W, SHANKLE R, KATZMAN R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992: 42: 473-80.
-
(1992)
Neurology
, vol.42
, pp. 473-480
-
-
Chui, H.C.1
Victoroff, J.I.2
Margolin, D.3
Jagust, W.4
Shankle, R.5
Katzman, R.6
-
9
-
-
0025801744
-
Apolipoprotein e genotyping by one-stage PCR
-
WENHAM PR, PRICE WH, BLUNDELL G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991: 337: 1158-9.
-
(1991)
Lancet
, vol.337
, pp. 1158-1159
-
-
Wenham, P.R.1
Price, W.H.2
Blundell, G.3
-
10
-
-
0027194791
-
Gene dose of apolipoprotein e type 4 allele and the risk of Alzheimer's disease in late onset families
-
CORDER EH, SAUNDERS AM, STRITTMATTER WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993: 261: 921-3
-
(1993)
Science
, vol.261
, pp. 921-923
-
-
Corder, E.H.1
Saunders, A.M.2
Strittmatter, W.J.3
-
11
-
-
0028278060
-
Protection against Alzheimer's disease with apoE ε 2
-
TALBOT C, LENDON C, CRADDOCK N, SHEARS S, MORRIS JC, GOATE A. Protection against Alzheimer's disease with apoE ε 2. Lancet 1994: 343: 1432-1433.
-
(1994)
Lancet
, vol.343
, pp. 1432-1433
-
-
Talbot, C.1
Lendon, C.2
Craddock, N.3
Shears, S.4
Morris, J.C.5
Goate, A.6
-
12
-
-
18744430888
-
Protective effect of apoE ε 2 in Alzheimer's disease
-
BENJAMIN R, LEAKE A, MCARTHUR FK, et al. Protective effect of apoE ε 2 in Alzheimer's disease. Lancet 1994: 344: 473.
-
(1994)
Lancet
, vol.344
, pp. 473
-
-
Benjamin, R.1
Leake, A.2
Mcarthur, F.K.3
-
13
-
-
0030010322
-
Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia
-
ISOE K, URAKAMI K, SATO K, TAKAHASH K. Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia. Acta Neurol Scand 1996: 93: 133-7.
-
(1996)
Acta Neurol Scand
, vol.93
, pp. 133-137
-
-
Isoe, K.1
Urakami, K.2
Sato, K.3
Takahash, K.4
-
14
-
-
0028990941
-
APOE 4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism
-
KAMBOH MI, SANGHER DK, FERREEL R, DEKOSKY S. APOE 4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nature Genet 1995: 10: 486-8.
-
(1995)
Nature Genet
, vol.10
, pp. 486-488
-
-
Kamboh, M.I.1
Sangher, D.K.2
Ferreel, R.3
Dekosky, S.4
-
16
-
-
0028274248
-
Association of apolipoprotein E E4 with vascular dementia
-
FRISONI GB, BIANCHETTI A, GOVONI S, TRABUCCHI M, CALABRESI L, FRANCESCHINI G. Association of apolipoprotein E E4 with vascular dementia. JAMA 1994: 271: 1317
-
(1994)
JAMA
, vol.271
, pp. 1317
-
-
Frisoni, G.B.1
Bianchetti, A.2
Govoni, S.3
Trabucchi, M.4
Calabresi, L.5
Franceschini, G.6
|